NYON, SWITZERLAND | Page 3 of 3

MedAlliance Receives Fourth FDA Breakthrough Device Designation for Sirolimus Drug-Eluting Balloon in Treatment of De Novo Coronary Lesions

MedAlliance, the first drug-eluting balloon (DEB) company in the world to receive US Food and Drug Administration (FDA) Breakthrough Device Designation Status for a sirolimus DEB, has now been awarded breakthrough status for SELUTION SLR™, its sustained limus release DEB catheter, in the treatment of atherosclerotic lesions in native coronary arteries. This is the fourth breakthrough […]

4 มี.ค. 64 14:40

thaipr.net

4 มี.ค. 64

The Swiss watch manufacturer Hublot, Official Timekeeper of the Premier League, announces a limited-edition version of the Big Bang e connected watch

Hublot, is proud to introduce the Big Bang e Premier League, a new evolution of its connected Big Bang with a dedicated application, new dial and new strap, in purple, the iconic color of the Premier League. “As a Hublot ambassador for many years, I can say that I am extremely proud to wear this […]

1 มี.ค. 64 8:01

thaipr.net

1 มี.ค. 64

First Patient Enrolled in SELUTION SLR™ SUCCESS PTA Study

MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon SELUTION SLR™ for the treatment of patients with peripheral artery disease (PAD). SELUTION SLR is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to that of a drug-eluting stent (DES). The […]

11 ก.พ. 64 14:40

thaipr.net

11 ก.พ. 64

12-Month Below-the-Knee Data with MedAlliance’s SELUTION SLR™ Presented as Late Breaking Trial at LINC

12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAlliance’s novel sirolimus-eluting balloon, for the treatment of long tibial occlusive lesions (TASC C & D) in patients with […]

29 ม.ค. 64 12:10

thaipr.net

29 ม.ค. 64

Hublot Launches New Big Bang Tourbillon Automatic Orange Sapphire

The art of fusion reaches a new level with a double endeavour at the limits of possibility Transparent, black, yellow, blue, red – Hublot has mastered the creation and machining of sapphires with exclusive shades for its watchcases. With the new Big Bang Tourbillon Automatic Orange Sapphire, the brand has once again achieved a world […]

27 ม.ค. 64 8:00

thaipr.net

27 ม.ค. 64

MedAlliance announces successful completion of enrolment in ISABELLA clinical trial for the treatment of failing AV fistulas in hemodialysis patients

MedAlliance has announced completion of patient enrolment in the ISABELLA Clinical Trial with SELUTION SLR™ 018 DEB (drug-eluting balloon) for the treatment of dysfunctional AV fistulas in end-stage renal failure patients undergoing hemodialysis. SELUTION SLR (Sustained Limus Release) is a novel sirolimus-eluting balloon that provides a controlled sustained release of drug, similar to a drug-eluting […]

25 พ.ย. 63 10:24

thaipr.net

25 พ.ย. 63

HUBLOT e-warranty: The digitisation of the warranty card or how each watch becomes its own certificate

The authenticity of Hublot watches is guaranteed by a visual recognition of the micro-structure of their materials. With the HUBLOT e-warranty, Hublot is launching a completely digital warranty stored in the AURA blockchain. To stay up-to-date, follow: @Hublot #Hublot “After being one of the first companies in the world to equip its watches with an […]

23 พ.ย. 63 13:41

thaipr.net

23 พ.ย. 63